<abstract xml:lang="en" xmlns="http://www.w3.org/1999/xhtml"><bold>Background.</bold> Metastatic paratesticular adenocarcinoma from the pancreatic cancer is very rare. To our knowledge, there are less than 20 cases published in the literature.<bold>Case report.</bold> We experienced a case of paratesticular adenocarcinoma from the primary pancreatic cancer. A 42-year-old man was presented with locoregionally advanced carcinoma of the tail of the pancreas with intraoperatively found liver metastases and with a tumour in the right hemi-scrotum. Ultrasound of the scrotum revealed a paratesticular tumour. A fine needle aspiration biopsy (FNAB) confirmed a poorly differentiated adenocarcinoma and it was in concordance with the diagnosis of the primary tumour. The patient started treatment with chemotherapy with gemcitabine. Unfortunately, he progressed one month later and the treatment was discontinued.<bold>Conclusions.</bold> Outcome in the adenocarcinoma of the pancreas is dismal. The only possible treatment option for metastatic disease is systemic therapy but the results are disappointing, as in the present case.</abstract>

Background. Metastatic paratesticular adenocarcinoma from the pancreatic cancer is very rare. To our knowledge, there are less than 20 cases published in the literature.Case report. We experienced a case of paratesticular adenocarcinoma from the primary pancreatic cancer. A 42-year-old man was presented with locoregionally advanced carcinoma of the tail of the pancreas with intraoperatively found liver metastases and with a tumour in the right hemi-scrotum. Ultrasound of the scrotum revealed a paratesticular tumour. A fine needle aspiration biopsy (FNAB) confirmed a poorly differentiated adenocarcinoma and it was in concordance with the diagnosis of the primary tumour. The patient started treatment with chemotherapy with gemcitabine. Unfortunately, he progressed one month later and the treatment was discontinued.Conclusions. Outcome in the adenocarcinoma of the pancreas is dismal. The only possible treatment option for metastatic disease is systemic therapy but the results are disappointing, as in the present case.

Paratesticular adenocarcinoma: unusual presentation of metastasis of pancreatic cancer

Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia

Radiology and Oncology

Background. Metastatic paratesticular adenocarcinoma from the pancreatic cancer is very rare. To our knowledge, there are less than 20 cases published in the...

Paratesticular adenocarcinoma: unusual presentation of metastasis of pancreatic cancer

Pubblicato online: 30 apr 2007

Pagine: 39 - 40

DOI: https://doi.org/10.2478/v10019-007-0006-9

Parole chiave
pancreatic neoplasms, neoplasms metastasis, testicular neoplasms - secondary

This content is open access.

Paratesticular adenocarcinoma: unusual presentation of metastasis of pancreatic cancer

Pubblicato online: 30 apr 2007

Pagine: 39 - 40

DOI: https://doi.org/10.2478/v10019-007-0006-9

Parole chiavepancreatic neoplasms, neoplasms metastasis, testicular neoplasms - secondary

This content is open access.

Parole chiave
pancreatic neoplasms, neoplasms metastasis, testicular neoplasms - secondary